Key facts
- Spiber Technologies’s last known valuation is $78.3M (Dec 2024).
- It has raised $11.7M; the latest was Later Stage VC ($5.9M) in Dec 2024.
- Notable investors include Alsteron, Uppsala Innovation Centre.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Spiber Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Spiber Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spiber Technologies
Developer of a biotechnology platform designed to offer recombinant technology for producing advanced biomaterials. The company's technology offers proprietary recombinant spider silk proteins which are difficult to be produced and are ideal for cell culturing, enabling medical professionals to use spider protein application areas in medical technology.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2008
- Employees
- 10
- Website
- spiber.se/
- Ownership
- Privately Held (backing)
Spiber Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spiber Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spiber Technologies in its N-PORT filings yet. We sweep new filings monthly.